We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Global Minimally Invasive Surgical (MIS) Instruments Market Driven by Growing Preference for MIS Procedures

By HospiMedica International staff writers
Posted on 17 Jul 2023
Print article
Image: The global minimally invasive surgical instruments market is expected to be worth USD 63 billion by 2030 (Photo courtesy of Konica Minolta)
Image: The global minimally invasive surgical instruments market is expected to be worth USD 63 billion by 2030 (Photo courtesy of Konica Minolta)

Minimally invasive surgical (MIS) procedures are designed to cause less trauma compared to traditional open surgeries, resulting in lower blood loss, minimal scarring, and reduced infection risks. The demand for MIS procedures is on the rise due to their less traumatic nature and the faster recovery process they offer. Patients are able to return to their daily activities quicker following MIS procedures. Additionally, MIS procedures are significantly more cost-effective compared to in-patient and traditional open surgeries. As a result, the global MIS instruments market is projected to grow at a CAGR of 10.3% from 2023 to 2030, reaching USD 63 billion in 2030.

These are the latest findings of Grand View Research (San Francisco, CA, USA), a market research and consulting company.

Based on device, the handheld instruments segment accounted for the largest revenue share of the MIS instruments market in 2022. However, the electrosurgical devices segment is predicted to experience the fastest growth rate during the forecast period from 2023 to 2030. On the basis of application, the orthopedic segment held the largest revenue share of the MIS instruments market in 2022. MIS procedures within orthopedics provide surgical options that cause minimal tissue disruption. Furthermore, the ongoing adoption of MIS techniques for spine-related procedures has led to an increase in procedural volumes for orthopedic MIS.

Based on end use, the hospital segment held the largest revenue share of the MIS instruments market in 2022. However, the ambulatory surgical center segment is expected to experience the fastest growth in the coming years. Geographically, North America held the majority share of the global MIS instruments market in 2022, primarily due to the supportive reimbursement framework for innovative MIS devices and procedures in the region.

Related Links:
Grand View Research

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Multi-Parameter Patient Monitor
S90
New
Aortic Valve Replacement System
INTUITY Elite

Print article

Channels

Critical Care

view channel
Image: The Atmo Gas Capsule measures gases as it travels through the GI tract and transmits the data wirelessly (Photo courtesy of Atmo Biosciences)

Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market

Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more

Surgical Techniques

view channel
Image: Intravascular imaging can improve outcomes for complex stenting procedures in patients with high-risk calcified coronary artery disease (Photo courtesy of Shutterstock)

Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures

Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more